83,200 Shares in Bruker Corporation $BRKR Bought by VeriStar Capital Management LP

Key Points

• VeriStar Capital Management LP acquired a new position in Bruker Corporation, purchasing 83,200 shares valued at approximately $3.47 million, making it the firm's 10th largest stock position.
• Bruker reported earnings of $0.32 per share for the last quarter, missing analyst expectations, and had a revenue of $797.4 million, which was below estimates.
• The company declared a quarterly dividend of $0.05, with the annual yield pegged at 0.6%, and the payout ratio currently stands at 38.46%.

VeriStar Capital Management LP acquired a new position in shares of Bruker Corporation (NASDAQ:BRKR - Free Report) in the 1st quarter, according to its most recent 13F filing with the SEC. The fund acquired 83,200 shares of the medical research company's stock, valued at approximately $3,473,000. Bruker comprises about 6.3% of VeriStar Capital Management LP's investment portfolio, making the stock its 10th largest holding. VeriStar Capital Management LP owned 0.05% of Bruker as of its most recent SEC filing.

Other institutional investors have also recently modified their holdings of the company. Teacher Retirement System of Texas raised its position in shares of Bruker by 5.1% during the 1st quarter. Teacher Retirement System of Texas now owns 29,045 shares of the medical research company's stock worth $1,212,000 after purchasing an additional 1,422 shares during the last quarter. Fifth Third Bancorp raised its holdings in Bruker by 54.2% in the 1st quarter. Fifth Third Bancorp now owns 1,109 shares of the medical research company's stock valued at $46,000 after acquiring an additional 390 shares during the last quarter. Wealth Enhancement Advisory Services LLC raised its holdings in Bruker by 81.2% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 29,826 shares of the medical research company's stock valued at $1,245,000 after acquiring an additional 13,367 shares during the last quarter. OneDigital Investment Advisors LLC raised its holdings in Bruker by 38.0% in the 1st quarter. OneDigital Investment Advisors LLC now owns 5,522 shares of the medical research company's stock valued at $230,000 after acquiring an additional 1,520 shares during the last quarter. Finally, UMB Bank n.a. raised its holdings in Bruker by 45.8% in the 1st quarter. UMB Bank n.a. now owns 1,325 shares of the medical research company's stock valued at $55,000 after acquiring an additional 416 shares during the last quarter. 79.52% of the stock is currently owned by institutional investors and hedge funds.

Bruker Trading Up 3.5%

Shares of NASDAQ BRKR traded up $1.04 during trading on Friday, hitting $30.83. 8,539,948 shares of the company traded hands, compared to its average volume of 3,799,900. Bruker Corporation has a 1 year low of $28.53 and a 1 year high of $72.94. The company has a 50-day moving average price of $37.12 and a 200-day moving average price of $39.68. The firm has a market capitalization of $4.68 billion, a P/E ratio of 59.29, a P/E/G ratio of 3.71 and a beta of 1.21. The company has a quick ratio of 0.70, a current ratio of 1.61 and a debt-to-equity ratio of 1.31.

Bruker (NASDAQ:BRKR - Get Free Report) last announced its quarterly earnings data on Monday, August 4th. The medical research company reported $0.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.33 by ($0.01). Bruker had a net margin of 2.31% and a return on equity of 17.89%. The company had revenue of $797.40 million for the quarter, compared to analysts' expectations of $811.17 million. During the same period in the prior year, the firm earned $0.52 earnings per share. The firm's quarterly revenue was down .4% on a year-over-year basis. Bruker has set its FY 2025 guidance at 1.950-2.050 EPS. On average, equities analysts predict that Bruker Corporation will post 2.69 EPS for the current year.

Bruker Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 3rd. Investors of record on Tuesday, September 23rd will be given a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend is Tuesday, September 23rd. Bruker's dividend payout ratio is 38.46%.

Analyst Ratings Changes

Several brokerages have weighed in on BRKR. Bank of America cut their price target on Bruker from $61.00 to $50.00 and set a "buy" rating for the company in a report on Thursday, June 26th. Citigroup cut their price target on Bruker from $40.00 to $38.00 and set a "neutral" rating for the company in a report on Monday, August 4th. Barclays cut their price target on Bruker from $46.00 to $43.00 and set an "overweight" rating for the company in a report on Monday, August 4th. Stifel Nicolaus set a $40.00 price target on Bruker and gave the company a "hold" rating in a report on Tuesday, August 5th. Finally, Jefferies Financial Group set a $60.00 price target on Bruker and gave the company a "buy" rating in a report on Monday, August 4th. Five investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $51.30.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.